Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trialPunnee Pitisuttithum, Bruce L. Innis, Piengthong Narakorn et al.|EClinicalMedicine|2022Cited by 56
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in VietnamAnh Duc Dang, Rami Scharf, Vũ Đình Thiểm et al.|Vaccine|2022Cited by 42
Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in VietnamAnh Duc Dang, Rami Scharf, Vũ Đình Thiểm et al.|medRxiv|2022Cited by 3